Antivenoms for Snakebite Envenoming: What Is in the Research Pipeline?
Main Authors: | Emilie Alirol, Pauline Lechevalier, Federica Zamatto, François Chappuis, Gabriel Alcoba, Julien Potet |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-09-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC4565558?pdf=render |
Similar Items
-
Snakebite envenoming at MSF: A decade of clinical challenges and antivenom access issues
by: Julien Potet, et al.
Published: (2023-03-01) -
Dose of antivenom for the treatment of snakebite with neurotoxic envenoming: Evidence from a randomised controlled trial in Nepal.
by: Emilie Alirol, et al.
Published: (2017-05-01) -
Availability, accessibility and use of antivenom for snakebite envenomation in Africa with proposed strategies to overcome the limitations
by: Mahmood Muazu Dalhat, et al.
Published: (2023-06-01) -
Acute Severe Anaphylaxis in Nepali Patients with Neurotoxic Snakebite Envenoming Treated with the VINS Polyvalent Antivenom
by: Sharma, S, et al.
Published: (2019) -
Dose of antivenom for the treatment of snakebite with neurotoxic envenoming: Evidence from a randomised controlled trial in Nepal
by: Alirol, E, et al.
Published: (2017)